Breathing treatment trial aims to help struggling newborns
NCT ID NCT07350421
Summary
This study is testing if a single dose of inhaled salbutamol can help newborns with a common breathing problem called Transient Tachypnea of the Newborn (TTN). The goal is to see if the treatment helps babies breathe easier, reduces their need for oxygen support, and shortens their hospital stay. The trial will compare babies who receive the medicine to those who receive a placebo (saltwater spray).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TTN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Latakia University
Latakia, Latakia Governorate, Syria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.